169 related articles for article (PubMed ID: 23149229)
1. 6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors.
Zhao XZ; Maddali K; Smith SJ; Métifiot M; Johnson BC; Marchand C; Hughes SH; Pommier Y; Burke TR
Bioorg Med Chem Lett; 2012 Dec; 22(24):7309-13. PubMed ID: 23149229
[TBL] [Abstract][Full Text] [Related]
2. Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors.
Zhao XZ; Maddali K; Metifiot M; Smith SJ; Vu BC; Marchand C; Hughes SH; Pommier Y; Burke TR
Chem Biol Drug Des; 2012 Feb; 79(2):157-65. PubMed ID: 22107736
[TBL] [Abstract][Full Text] [Related]
3. Bicyclic 1-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-containing HIV-1 integrase inhibitors having high antiviral potency against cells harboring raltegravir-resistant integrase mutants.
Zhao XZ; Smith SJ; Métifiot M; Johnson BC; Marchand C; Pommier Y; Hughes SH; Burke TR
J Med Chem; 2014 Feb; 57(4):1573-82. PubMed ID: 24471816
[TBL] [Abstract][Full Text] [Related]
4. 6,7-Dihydroxyisoindolin-1-one and 7,8-Dihydroxy-3,4-Dihydroisoquinolin- 1(2H)-one Based HIV-1 Integrase Inhibitors.
Zhao XZ; Metifiot M; Smith SJ; Maddali K; Marchand C; Hughes SH; Pommier Y; Burke TR
Curr Top Med Chem; 2016; 16(4):435-40. PubMed ID: 26268341
[TBL] [Abstract][Full Text] [Related]
5. 4-amino-1-hydroxy-2-oxo-1,8-naphthyridine-containing compounds having high potency against raltegravir-resistant integrase mutants of HIV-1.
Zhao XZ; Smith SJ; Métifiot M; Marchand C; Boyer PL; Pommier Y; Hughes SH; Burke TR
J Med Chem; 2014 Jun; 57(12):5190-202. PubMed ID: 24901667
[TBL] [Abstract][Full Text] [Related]
6. Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors.
Zhao XZ; Maddali K; Metifiot M; Smith SJ; Vu BC; Marchand C; Hughes SH; Pommier Y; Burke TR
Bioorg Med Chem Lett; 2011 May; 21(10):2986-90. PubMed ID: 21493066
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 integrase strand-transfer inhibitors: design, synthesis and molecular modeling investigation.
De Luca L; De Grazia S; Ferro S; Gitto R; Christ F; Debyser Z; Chimirri A
Eur J Med Chem; 2011 Feb; 46(2):756-64. PubMed ID: 21227550
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines.
Brzozowski Z; Saczewski F; Sanchez T; Kuo CL; Gdaniec M; Neamati N
Bioorg Med Chem; 2004 Jul; 12(13):3663-72. PubMed ID: 15186851
[TBL] [Abstract][Full Text] [Related]
9. Caffeoyl naphthalenesulfonamide derivatives as HIV integrase inhibitors.
Xu YW; Zhao GS; Shin CG; Zang HC; Lee CK; Lee YS
Bioorg Med Chem; 2003 Aug; 11(17):3589-93. PubMed ID: 12901903
[TBL] [Abstract][Full Text] [Related]
10. Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors.
Serrao E; Odde S; Ramkumar K; Neamati N
Retrovirology; 2009 Mar; 6():25. PubMed ID: 19265512
[TBL] [Abstract][Full Text] [Related]
11. In Vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitor.
Kobayashi M; Yoshinaga T; Seki T; Wakasa-Morimoto C; Brown KW; Ferris R; Foster SA; Hazen RJ; Miki S; Suyama-Kagitani A; Kawauchi-Miki S; Taishi T; Kawasuji T; Johns BA; Underwood MR; Garvey EP; Sato A; Fujiwara T
Antimicrob Agents Chemother; 2011 Feb; 55(2):813-21. PubMed ID: 21115794
[TBL] [Abstract][Full Text] [Related]
12. Microwave assisted organic synthesis (MAOS) of small molecules as potential HIV-1 integrase inhibitors.
Ferro S; Grazia SD; De Luca L; Gitto R; Faliti CE; Debyzer Z; Chimirri A
Molecules; 2011 Aug; 16(8):6858-70. PubMed ID: 21836543
[TBL] [Abstract][Full Text] [Related]
13. Diketoacid inhibitors of HIV-1 integrase: from L-708,906 to raltegravir and beyond.
Beare KD; Coster MJ; Rutledge PJ
Curr Med Chem; 2012; 19(8):1177-92. PubMed ID: 22214459
[TBL] [Abstract][Full Text] [Related]
14. Design and discovery of 5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide inhibitors of HIV-1 integrase.
Zhang D; Debnath B; Yu S; Sanchez TW; Christ F; Liu Y; Debyser Z; Neamati N; Zhao G
Bioorg Med Chem; 2014 Oct; 22(19):5446-53. PubMed ID: 25150089
[TBL] [Abstract][Full Text] [Related]
15. Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1.
Hassounah SA; Alikhani A; Oliveira M; Bharaj S; Ibanescu RI; Osman N; Xu HT; Brenner BG; Mesplède T; Wainberg MA
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923862
[TBL] [Abstract][Full Text] [Related]
16. Development of a phenotypic susceptibility assay for HIV-1 integrase inhibitors.
Heger E; Theis AA; Remmel K; Walter H; Pironti A; Knops E; Di Cristanziano V; Jensen B; Esser S; Kaiser R; Lübke N
J Virol Methods; 2016 Dec; 238():29-37. PubMed ID: 27737783
[TBL] [Abstract][Full Text] [Related]
17. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
[TBL] [Abstract][Full Text] [Related]
18. Structure-Guided Optimization of HIV Integrase Strand Transfer Inhibitors.
Zhao XZ; Smith SJ; Maskell DP; Métifiot M; Pye VE; Fesen K; Marchand C; Pommier Y; Cherepanov P; Hughes SH; Burke TR
J Med Chem; 2017 Sep; 60(17):7315-7332. PubMed ID: 28737946
[TBL] [Abstract][Full Text] [Related]
19. Structure activity of 3-aryl-1,3-diketo-containing compounds as HIV-1 integrase inhibitors.
Pais GC; Zhang X; Marchand C; Neamati N; Cowansage K; Svarovskaia ES; Pathak VK; Tang Y; Nicklaus M; Pommier Y; Burke TR
J Med Chem; 2002 Jul; 45(15):3184-94. PubMed ID: 12109903
[TBL] [Abstract][Full Text] [Related]
20. Chemical modification of coumarin dimer and HIV-1 integrase inhibitory activity.
Mao PC; Mouscadet JF; Leh H; Auclair C; Hsu LY
Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1634-7. PubMed ID: 12499608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]